Literature DB >> 24752468

Formula versus donor breast milk for feeding preterm or low birth weight infants.

Maria Quigley1, William McGuire.   

Abstract

BACKGROUND: When sufficient maternal breast milk is not available, alternative sources of enteral nutrition for preterm or low birth weight infants are donor breast milk or artificial formula. Donor breast milk may retain some of the non-nutritive benefits of maternal breast milk for preterm or low birth weight infants. However, feeding with artificial formula may ensure more consistent delivery of optimal levels of nutrients. Uncertainty exists about the balance of risks and benefits of feeding formula versus donor breast milk for preterm or low birth weight infants.
OBJECTIVES: To determine the effect of feeding with formula compared with donor breast milk on growth and development in preterm or low birth weight infants. SEARCH
METHODS: We searched the Cochrane Central Register of Controlled Trials (CENTRAL 2014, Issue 3), MEDLINE (1966 to March 2014), EMBASE (1980 to March 2014), CINAHL (1982 to March 2014), conference proceedings and previous reviews. SELECTION CRITERIA: Randomised or quasi-randomised controlled trials comparing feeding with formula versus donor breast milk in preterm or low birth weight infants. DATA COLLECTION AND ANALYSIS: We extracted data using the standard methods of the Cochrane Neonatal Group, with separate evaluation of trial quality and data extraction by two review authors. MAIN
RESULTS: Nine trials, in which 1070 infants participated, fulfilled the inclusion criteria. Four trials compared standard term formula versus donor breast milk and five compared nutrient-enriched preterm formula versus donor breast milk. Only the two most recent trials used nutrient-fortified donor breast milk. The trials contain various methodological quality weaknesses, specifically uncertainty about adequate allocation concealment methods in three trials and lack of blinding in most of the trials.Formula-fed infants had higher in hospital rates of increase in weight [mean difference (MD): 2.58 (95% confidence interval (CI) 1.98 to 3.71) g/kg/day], length [MD 1.93 (95% CI 1.23 to 2.62) mm/week] and head circumference [MD 1.59 (95% CI 0.95 to 2.24) mm/week]. We did not find evidence of an effect on post-discharge growth rates or neurodevelopmental outcomes. Formula feeding increased the risk of necrotising enterocolitis: typical risk ratio 2.77 (95% CI 1.40 to 5.46); risk difference 0.04 (95% CI 0.02 to 0.07). AUTHORS'
CONCLUSIONS: In preterm and low birth weight infants, feeding with formula compared with donor breast milk results in a higher rate of short-term growth but also a higher risk of developing necrotising enterocolitis. Limited data on the comparison of feeding with formula versus nutrient-fortified donor breast milk are available. This limits the applicability of the findings of this review as nutrient fortification of breast milk is now a common practice in neonatal care. Future trials may compare growth, development and adverse outcomes in infants who receive formula milk versus nutrient-fortified donor breast milk given as a supplement to maternal expressed breast milk or as a sole diet.

Entities:  

Mesh:

Year:  2014        PMID: 24752468     DOI: 10.1002/14651858.CD002971.pub3

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  97 in total

Review 1.  Working group reports: evaluation of the evidence to support practice guidelines for nutritional care of preterm infants-the Pre-B Project.

Authors:  Daniel J Raiten; Alison L Steiber; Susan E Carlson; Ian Griffin; Diane Anderson; William W Hay; Sandra Robins; Josef Neu; Michael K Georgieff; Sharon Groh-Wargo; Tanis R Fenton
Journal:  Am J Clin Nutr       Date:  2016-01-20       Impact factor: 7.045

2.  Room for improvement in breast milk feeding after very preterm birth in Europe: Results from the EPICE cohort.

Authors:  Emilija Wilson; Anna-Karin Edstedt Bonamy; Mercedes Bonet; Liis Toome; Carina Rodrigues; Elizabeth A Howell; Marina Cuttini; Jennifer Zeitlin
Journal:  Matern Child Nutr       Date:  2017-07-17       Impact factor: 3.092

3.  The availability of probiotics and donor human milk is associated with improved survival in very preterm infants.

Authors:  Janet Sharpe; Mandy Way; Pieter J Koorts; Mark W Davies
Journal:  World J Pediatr       Date:  2018-06-27       Impact factor: 2.764

Review 4.  Probiotics, Prebiotics, and Synbiotics for the Prevention of Necrotizing Enterocolitis.

Authors:  Kathene C Johnson-Henry; Thomas R Abrahamsson; Richard You Wu; Philip M Sherman
Journal:  Adv Nutr       Date:  2016-09-15       Impact factor: 8.701

5.  Factors associated with feeding progression in extremely preterm infants.

Authors:  Jinhee Park; George Knafl; Suzanne Thoyre; Debra Brandon
Journal:  Nurs Res       Date:  2015 May-Jun       Impact factor: 2.381

Review 6.  Evidence-Based Methods That Promote Human Milk Feeding of Preterm Infants: An Expert Review.

Authors:  Paula P Meier; Tricia J Johnson; Aloka L Patel; Beverly Rossman
Journal:  Clin Perinatol       Date:  2016-12-27       Impact factor: 3.430

7.  Effect of Pooling Practices and Time Postpartum of Milk Donations on the Energy, Macronutrient, and Zinc Concentrations of Resultant Donor Human Milk Pools.

Authors:  Bridget E Young; Laraine L Borman; Rebecca Heinrich; Julie Long; Sarah Pinney; Jamie Westcott; Nancy F Krebs
Journal:  J Pediatr       Date:  2019-09-23       Impact factor: 4.406

Review 8.  A critical analysis of risk factors for necrotizing enterocolitis.

Authors:  Allison Thomas Rose; Ravi Mangal Patel
Journal:  Semin Fetal Neonatal Med       Date:  2018-08-01       Impact factor: 3.926

Review 9.  Intestinal microbiota and its relationship with necrotizing enterocolitis.

Authors:  Ravi Mangal Patel; Patricia W Denning
Journal:  Pediatr Res       Date:  2015-05-20       Impact factor: 3.756

Review 10.  Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants.

Authors:  Sam J Oddie; Lauren Young; William McGuire
Journal:  Cochrane Database Syst Rev       Date:  2017-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.